
    
      30 healthy subjects will be randomized to one of the 2 groups in the same ratio.

      Subjects in group 1 will be administered "comparator" and "YHP1906 Tab. 5 mg" by cross-over
      design on day 1, 8.

      Subjects in group 2 will be administered "YHP1906 Tab. 5 mg" and "comparator" by cross-over
      design on day 1, 8
    
  